匯友生命科學(08088.HK)出售AID Partners Autonomous股本 套現210萬元
匯友生命科學(08088.HK)公布,集團與買方Vantage Elite Holdings Limited訂立出售協議。據此,旗下全資附屬公司New Earn Investments Limited有條件同意向買方出售普通合夥人AID Partners Autonomous GP Ltd股本中面值1.00美元之普通股1股,即普通合發夥人之全部已發行股本,現金代價為27萬美元(相當於約210萬港元)。
於完成後,公司將不再擁有普通合夥人之任何股權,而普通合夥人將不再為公司之附屬公司。由於進行出售事項,集團不再透過普通合夥人擁有對合夥企業之管理及投資控制權。因此,儘管集團仍保留其對合夥企業之出資,惟合夥企業及其附屬公司不再入賬列作公司之附屬公司。出售事項等同視作出售合夥企業及其附屬公司。
公司指,出售事項所得款項淨額約150萬元將用作集團之一般營運資金。這是自美國公司撤資之部份程序,原因為其價值自集團於2016年購入以來有所升值,並旨在償還可換股債券以及為集團業務營運及發展提供資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.